NCT02044848View on ClinicalTrials.gov

Study of Secukinumab in Patients With Newly-diagnosed Type 1 Diabetes Mellitus

PHASE2TerminatedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
Type 1 Diabetes Mellitus
Interventions
DRUG

Secukinumab

DRUG

Placebo

Placebo

Trial Locations (2)

10032

Novartis Investigative Site, New York

98122

Novartis Investigative Site, Seattle

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY